Bipolar Disorder Trial, Recruiting (NCT05409794)

Bipolar Disorder Trial, Recruiting NCT05409794 Sponsor: University Hospital, Montpellier Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT05409794 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People currently experiencing a major depressive episode, as defined by standard psychiatric diagnostic guidelines (DSM-5)
People who have not been treated with lithium-based medication in the past 12 months
For the suicidal attempters/ideation group only: people who have had a suicidal event (attempt or serious thoughts of suicide) within the past 12 months
For the comparison group only: people who have had no suicidal event in the past 12 months

Who may not be able to join:

People who have ever been diagnosed with schizoaffective disorder, schizophrenia, or psychosis
People who are pregnant or breastfeeding
People who are currently restricted of their freedom due to a legal or administrative decision (for example, those in detention)
People who are under a legal protection arrangement, such as guardianship or being under a curator
People who are unable to understand the study procedures
People who are not enrolled in the French National Social Security System
People who have not given their consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33467338581

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05409794

Sponsor: University Hospital, Montpellier

Phase: Not Applicable

Status: Recruiting

Condition: Bipolar Disorder

Trial contact: +33467338581

More information: https://clinicaltrials.gov/study/NCT05409794

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People currently experiencing a major depressive episode, as defined by standard psychiatric diagnostic guidelines (DSM-5)
People who have not been treated with lithium-based medication in the past 12 months
For the suicidal attempters/ideation group only: people who have had a suicidal event (attempt or serious thoughts of suicide) within the past 12 months
For the comparison group only: people who have had no suicidal event in the past 12 months

Who may not be able to join:

People who have ever been diagnosed with schizoaffective disorder, schizophrenia, or psychosis
People who are pregnant or breastfeeding
People who are currently restricted of their freedom due to a legal or administrative decision (for example, those in detention)
People who are under a legal protection arrangement, such as guardianship or being under a curator
People who are unable to understand the study procedures
People who are not enrolled in the French National Social Security System
People who have not given their consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Montpellier

Registry

ClinicalTrials.gov

Start date

9 December 2022

Est. completion

9 January 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Patients rate with lithium levels above 0.1 µeq/L

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov